Temanummer om biomonitering - Sundhedsstyrelsens RÃ¥dgivende ...

for phthalater og organisering af og indsamling
af prøver, prøveoparbejdning, spørgeskemaer
m.m. Studiet er planlagt koordineret fra
Københavns Universitet med indsamling af
prøver etc. og analyser for metaller og kotinin i
Odense ved Syddansk Universitet og for phthalater
på Rigshospitalet, med tilkendegivelser
fra Miljøstyrelsen, Sundhedsstyrelsen og Fødevaredirektoratet
om medfinansiering af den
halvdel, som medlemslandene selv skal betale.
Tidsplanen er start 2010 med et treårigt forløb,
hvor de fleste aktiviteter vil ligge i 2011 og
2012 med prøveindsamlinger og analyser.
En tværinstitutionel gruppe med repræsentanter
fra de tre styrelser, Københavns, Syddansk
og Århus universiteter samt Danmarks
Tekniske Universitet skal sikre, at danske
miljøer med interesse for human biomonitering
holdes opdateret om denne aktivitet.
DEMOCOPHES vil bidrage med nationale
data vedr. eksponering, give mulighed for sammenligninger
og et egentligt måleprogram til
overvågning af befolkningernes baggrundseksponeringer.
Udbyttet for Danmark ved deltagelse er harmoniseret
tilgang til human biomonitering med
mulighed for sammenligninger og udveksling
af prøver og resultater. Scenarier ud over basisscenariet
skal betales særskilt, men prøverne
vil foreligge, og vi vil vedblive med at søge
dette dækket i nationale fonde m.m.
OFFICIEL tekst om COPHES II
This proposal has been elaborated by a consortium
of 35 partners coming from 27 European
countries and including scientists, government
institutions and authorities, NGOs and industry.
The main goal is to develop a coherent
approach to HBM in Europe as requested by
ACTION 3 of the EU Environment and Health
Action Plan through coordination of ongoing
and planned HBM activities.
The project will exploit existing and planned
HBM projects and programmes of work and
capabilities in Europe. The consortium will
investigate what is needed to advance and
improve comparability of HBM data across
Europe. Work prepared under DG Research
and DG Environment activities dealing with
development, validation and use of novel biomarkers
including non-invasive markers and
effect markers will be exploited. Through close
collaboration with similar initiatives in the
field of Health - such as the EU Health Examination
Survey - appropriate economies and
efficiencies will be assessed. Key issues such
as Ethics and human Biobanks will be
addressed. The project will deliver a number of
key outputs including:
1. Tested Proofs of Concept and/or Demonstration
project assessing the feasibility of
a coordinated approach, including strategies
for data interpretation & integration
with environmental and health
data.
2. A rationale and strategy for communication
and dissemination of information, results
and key messages to all stakeholders
from the public to policy makers.
3. Training and capacity building will aim to
promote knowledge and experience exchange
and development in the field of
HBM within Europe. A common understanding
within all parties involved on the
potential of HMB in supporting and evaluating
current/future policy making (including
e.g. REACH) and for environmental
health awareness raising will be promoted
This project’s aim is to significantly advance
the process towards a fully operational,
continuous, sustainable and scientifically
sound EU HBM programme.
Yderligere oplysninger: Lisbeth E. Knudsen,
L.Knudsen@pubhealth.ku.dk
90 miljø og sundhed 15. årgang, supplement nr. 1, oktober 2009